APPLICATIONS PUBLISHED 5 MARCH 2003
Published: 1-Aug-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Improvements in or relating to perfumes
Quest International 1286651*
Skin protectant spray compsns
Pfizer Products 1286652*
Compsns containing at least one aryl oxime and at least one active substance for treating acne and use thereof
Merck Patent 1286653*
Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reactions of the skin
Merck Patent 1286654*
Topical compsn containing at least one aryl oxime, and method for the preparation thereof
Merck Patent 1286655*
Detergent containing alpha-sulfo-fatty acid esters and methods of making and using the same
Huish Detergents 1286656*
Nasal ointment based on white petroleum jelly
Phyt-Immun 1286657*
Y-ifn liquid-droplet aerosol and method
Intermune 1286658*
Macromolecular drug complexes and compsns containing the same
Board of Trustees of the University of Illinois 1286659*
Pharmaceutical compsn in liquid form for oral administration of an active principle, with an unpleasant, in particular bitter, taste
Laboratoires Crinex 1286660*
Liposomal benzoquinazoline thymidylaet synthase inhibitor formulations
Ost Pharmaceuticals 1286661*
Tablets and methods for modified release of hydrophobic and other active agents
Yamanouchi Pharma Technologies; Yamanouchi Pharmaceuticals 1286662*
Encapsulating a toxic core within a non-toxic region in an oral dosage form
Therics; Massachusetts Institute of Technology 1286663*
Method of treating immune pathologies with low dose estrogen
Oregon Health Sciences University; The United States of America Through the Department of Veterans Affairs 1286664*
Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
Novartis 1286665*
Starter kit for low dose oral contraceptives
Wyeth 1286666*
Compsn for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
Merck Patent 1286667*
Pharmaceutical compsns and their use in treating gastrointestinal disorders
Novartis 1286668*
Methods for prevention of ulcers and improving physiological performance
Merial 1286669*
Use of therapeutic benzamide derivatives
Glaxo Group 1286670*
Compsns for the treatment of colorectal cancer comprising thalidomide and irinotecan
Celgene Corp; The Board of Trustees of the University of Arkansas 1286671*
S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
Pfizer Products 1286672*
Ligands of integrin receptors
BASF 1286673*
Methods and compsns for potentiating cancer chemotherapeutic agents
Oxycal Laboratories 1286674*
Method for increasing the antioxidative potential of selenium-containing aqueous solutions
Okopharm Forschungs- und Entwicklungs-GmbH 1286675*
Bismuth compounds for the treatment and prevention of mucositis
Geltex Pharmaceuticals 1286676*
Purified material having size and growth inhibitory effects on cells and tissues
Endocrine Pharmaceutical 1286677*
Combination of mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
Sloan-Kettering Institute for Cancer Research 1286678*
Skin treatment preparation
Life Science Investment 1286679*
Seaweed supplement diet for enhancing immune response in mammals and poultry
Texas Tech University 1286680*
Irradiation of ispaghula
Reckitt Benckiser Healthcare 1286681*
Methods and compsns for inhibiting immunoglobulin-mediated-reperfusion injury
The Center for Blood Research 1286682*
A method of treatment of amyotrphic lateral sclerosis with a protein extractable from mammalian organs
Rakepoll Holding 1286683*
CXCR4 antagonist treatment of hematopoietic cells
The University of British Columbia; Chemokine Therapeutics 1286684*
A method of treatment of Parkinson's disease with a protein extractable from mammalian organs
Rakepoll Holding 1286685*
Methods for preventing strokes by inducing tolerance to e-selectin
The Government of the United States of America as represented by the Secretary of Health and Human Services 1286686*
A method of treatment of Huntington's chorea with a protein extractable from mammalian organs
Rakepoll Holding 1286687*
A method of treatment of Alzheimer's disease with a protein extractable from mammalian organs
Rakepoll Holding 1286688*
Human growth hormone to stimulate mobilisation of pluripotent hematopoietic stem cells
Applied Research Systems 1286689*
Use of alpha-MSH and EPO for preventing or treating ischaemic conditions
Action Pharma 1286690*
Methods for treatment of diseases associated with inflammation under non-ischaemic conditions
Action Pharma 1286691*
Intrathecal administration of rituximab for treatment of central nervous system lymphomas
Idec Pharmaceuticals 1286692*
Complexes of alpha-2 macroglobulin and antigenic molecules for immunotherapy
University of Connecticut Health Centre 1286693*
Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
Genphar 1286694*
Antigenic compsn comprising a polycationic peptide and inosine and cytosine
Intercell Biomedizinische Forschungs- und Entwicklungs 1286695*
Outer membrane vesicle vaccine against disease caused my Neisseria meningitis serogroup A and process for the production thereof
Statens Institutt for Folkehelse 1286696*
